1型糖尿病带来的心血管负担常因患者年龄较轻以及长期以来对微血管而非大血管并发症的关注而被忽视。这种错位历史上导致对1型糖尿病患者心血管风险因素的治疗不足，其心血管后果至今仍然明显。在此背景下，Patrik Smidtslund 及其同事的分析[1]为1型糖尿病心肌梗死的自然史提供了重要见解，并挑战了关于该人群冠心病表现的长期假设。
参考文献
- Smidtslund P, Harjutsalo V, Thorn V, et al. Comparison of incidence patterns and risk profiles of ST-elevation and non-ST-elevation myocardial infarction in type 1 diabetes in Finland: a nationwide cohort study. Lancet Diabetes Endocrinol. 2025; published online March 20.
- Harjutsalo V, Pongrac Barlovic D, Groop PH. Long-term population-based trends in the incidence of cardiovascular disease in individuals with type 1 diabetes from Finland: a retrospective, nationwide, cohort study. Lancet Diabetes Endocrinol. 2021; 9:575-585.
- Patsoukaki V, Lind L, Lampa E, et al. Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data. Lancet Diabetes Endocrinol. 2025; 13:848-862.
- Brownrigg JR, Hughes CO, Burleigh D, et al. Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrinol. 2016; 4:588-597.
- Heerspink HJ, Cherney DZ, Groop PH, et al. People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action. Lancet Diabetes Endocrinol. 2023; 11:536-540.
- Anson M, Zhao SS, Austin P, et al. SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study. Diabetologia. 2023; 66:1869-1881.
- Steineck I, Cederholm J, Eliasson B, et al. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study. BMJ. 2015; 350:h3234.
【全文结束】